Sleep quality and daytime sleepiness are not associated with cognition in heart failure

Fawn A Walter1, David Ede1, Misty A W Hawkins2

  • 1Kent State University, Department of Psychological Sciences, P.O. Box 5190, Kent, OH 44240, USA.

Insights

Sleep quality and daytime sleepiness do not impact cognitive function in heart failure (HF) patients. Other factors significantly influence cognitive performance in individuals with HF, suggesting a need for further research into these determinants.

Area of Science:

  • Cardiology
  • Neurology
  • Sleep Medicine

Background:

  • Heart failure (HF) is frequently accompanied by cognitive impairments and sleep disturbances.
  • Existing research on the relationship between sleep quality and cognitive function in HF patients presents inconsistent findings.
  • This study investigates the association between sleep quality, daytime sleepiness, and cognitive performance in individuals with HF.

Purpose of the Study:

  • To examine the relationship between sleep quality and cognitive function in stable heart failure patients.
  • To assess the association between daytime sleepiness and cognitive performance in this population.
  • To identify potential factors influencing cognitive function in heart failure.

Main Methods:

  • A cross-sectional analysis of 267 stable heart failure patients from outpatient settings.
  • Cognitive function assessed across global, attention, memory, and executive domains.
  • Sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI) and daytime sleepiness by the Epworth Sleepiness Scale (ESS).
  • Multiple hierarchical linear regressions controlled for demographic and clinical variables.

Main Results:

  • No statistically significant association was found between cognitive function and sleep quality after adjusting for multiple comparisons.
  • Similarly, no significant association was observed between cognitive function and daytime sleepiness.
  • These findings suggest that sleep parameters may not be primary drivers of cognitive deficits in this HF cohort.

Conclusions:

  • Cognitive function in heart failure patients is not significantly associated with sleep quality or daytime sleepiness.
  • Other unmeasured or unadjusted factors likely play a more substantial role in cognitive performance.
  • Further research is warranted to explore alternative determinants of cognitive impairment in heart failure.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
952
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
983
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
330